COMPREHENSIVE RESPONSE HEADQUARTERS FOR U.S. TARIFF MEASURES

TOKYO, July 8 -- Prime Minister and His Cabinet issued the following highlight: On July 8, 2025, Prime Minister Ishiba held the fifth meeting of the Comprehensive Response Headquarters for U.S. Tariff Measures at the Prime Minister's Office. At the meeting, the participants engaged in discussions on response to U.S. tariff measures. Disclaimer: Curated by HT Syndication....


KEYNOTE MESSAGE BY HIS MAJESTY THE EMPEROR OF JAPAN THE 7TH SPECIAL THEMATIC SESSION ON WATER AND DISASTERS "WATER AND DISASTERS FOR COOPERATION AND PARTNERSHIPS" (THROUGH VIDEO)

TOKYO, July 8 -- The Imperial Household Agency issued the following news: Your Excellency Dr. Han Seung-soo, Chair of HELP, Excellencies, Ladies and Gentlemen, 1 Prologue I am pleased to give this keynote message to the 7th Special Thematic Session on Water and Disasters. Before I begin, I would like to highlight that an earthquake measuring 7.7 on the Ritcher scale hit the Sagaing Region of Myanmar, affecting the country, Thailand, China and other places. There have been recurrent disasters ...


Empowering Design Education: ARCH Jaipur's Archana Surana Re-Elected to Global Cumulus Board

India, July 8 -- Jaipur: Archana Surana, Founder and Director of ARCH College of Design & Business, Jaipur, has been re-elected to the 11-member Executive Board of the prestigious Cumulus Global Association of Art & Design Education and Research for the 2025-2028 term. The announcement came during the Cumulus Nantes 2025 conference held in France, which brought together leading global voices in art, design, and media education.Cumulus Association is an international network presently comprising ...


Renowned Indian Cardiac Surgeon Dr. Lokeswara Rao Sajja Inducted as Associate Member of Prestigious Sigma Xi Scientific Research Honor Society

India, July 8 -- Dr. Lokeswara Rao Sajja, Senior Consultant Cardiothoracic Surgeon at STAR Hospitals and Chairman of the Sajja Heart Foundation, has been inducted as anAssociate Member of Sigma Xi, The Scientific Research Honor Society-one of the world's oldest and most respected organizations dedicated to the advancement of science and research.Founded in1886 at Cornell University, USA, Sigma Xi has a long legacy of supporting excellence in scientific research and fostering collaboration among ...


Beyond Numbers: How Dr Pyarilal Tripathy is transforming the dreams of Parenthood through IVF.

India, July 8 -- Bargarh, Odisha | July 2025 - In a country where Infertility is misunderstood and criticised and is emotionally draining, one man and his team have silently been changing lives, turning sadness into happiness.Dr Pyarilal Tripathy founder and Chief Fertility Specialist at Kishori IVF is not only delivering results, but also hope and dreams.Over the past 13 years, from 2012 to 2025, over 2100 families have found happiness and a new beginning at Kishori IVF. But this milestone not ...


Clinical Trial: Functionality verification test by continuous intake of test food: a randomized, double blind, placebo-controlled study (Japan)

Tokyo, July 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058384) titled 'Functionality verification test by continuous intake of test food' on July 8. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - Japan Clinical Trial Association Condition: Condition - Healthy adult Classification by malignancy - Oth...


Clinical Trial: Use-result survey to evaluate the safety and outcome of QUVIVIQ use in patients with insomnia (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058402) titled 'Use-result survey to evaluate the safety and outcome of QUVIVIQ use in patients with insomnia' on July 8. Study Type: Observational Primary Sponsor: Institute - Nxera Pharma Japan Co.,Ltd Condition: Condition - insomnia Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - To evaluate the safety and efficacy of QUVIVIQ Tablet...


Clinical Trial: Evaluation of short-term changes in glycemic management indicators before and after initiating once-weekly basal insulin icodec: A multicenter, exploratory, prospective, single-arm observational study (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058398) titled 'Evaluation of short-term changes in glycemic management indicators before and after initiating once-weekly basal insulin' on July 8. Study Type: Observational Primary Sponsor: Institute - Asahikawa Medical University Condition: Condition - Type 2 diabetes Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - To evaluate the s...


Clinical Trial: The effect of press needles on myofascial pain syndrome in patients with advanced cancer (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058406) titled 'The effect of press needles on myofascial pain syndrome in patients with advanced cancer' on July 8. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control Primary Sponsor: Institute - NHO Hokkaido Cancer Center Condition: Condition - myofascial pain syndrome Classifica...


Clinical Trial: Evaluation of the Behavioral Change Effects of an Integrated Program on Oral Health and Food Education for Elementary School Children (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058399) titled 'Evaluation of the Behavioral Change Effects of an Integrated Program on Oral Health and Food Education for Elementary School Children' on July 8. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled Primary Sponsor: Institute - Institute of Science Tokyo Condition: Co...